☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
Frontotemporal Dementia-Granulin
Takeda Exercises its Option with Denali to Co-Develop and Co-Commercialize DNL593 (PTV:PGRN) for Frontotemporal Dementia-Granulin
November 18, 2021
Merck KGaA Collaborated with Burning Rock for Liquid-biopsy Based CDx Development
November 18, 2021
Load more...
Back to Home
